Connect with us

“More Dangerous Than You Think” – Global Stock Market Cap Tops $100 Trillion For First Time Ever

"More Dangerous Than You Think" – Global Stock Market Cap Tops $100 Trillion For First Time Ever

Tyler Durden

Mon, 12/07/2020 – 17:34

One hundred trillion dollars… that’s a 1 followed by 14 zeros! That is the current market capita

Published

on

"More Dangerous Than You Think" - Global Stock Market Cap Tops $100 Trillion For First Time Ever Tyler Durden Mon, 12/07/2020 - 17:34

One hundred trillion dollars... that's a 1 followed by 14 zeros! That is the current market capitalization of global stock markets - a level never before seen in history.

Source: Bloomberg

Remember when $100,000,000,000,000 was a lot of money? For some context, World GDP was around $85 trillion at the end of 2019 (and as stock market values have soared in 2020, GDP has not)...

Source: Bloomberg

Interestingly, the global bond market's value also reached a record high at over $66 trillion, meaning that $14 trillion in global liquidity added since the March crash lows has lifted global bond and stock markets by a stunning $50 trillion ($40 trillion or so in stock and $10 trillion or so in bonds).

And judging by the smorgasbord of strategist forecasts for 2021, there is no stopping this surge (until of course, it all goes full Thelma-and-Louise and confidence in global fiat collapses).

JPMorgan sees the S&P 500 at 4,500 by the end of 2021, which, if 2020 is anything to go by, means an additional $10 trillion in global liquidity will be required to inflate the index's value...

Source: Bloomberg

Which is ironic since, as Daniel Lacalle detailed earlier,  also according to JP Morgan, equity markets have not been this expensive so early into an economic recovery phase in the last twenty years.

The Greed vs Fear Index also shows extreme optimism, while the Call to Put ratio in derivatives, that reflects the derivative exposure to a rising market, is also at multi-year highs. Meanwhile, the amount of negative-yielding bonds globally has risen to almost $18 trillion...

...and the High Yield Index has risen to pre-crisis levels (and spreads to record lows).

Many factors explain this level of optimism in markets. The news about vaccines and estimates of a rapid economic recovery accelerated investors’ bullish bets.

However, we must remember that all consensus estimates for 2021 already discounted the end of the pandemic, and that the quick recovery so many hoped for is not happening, and definitely not in a way that would justify the aggressive increase in risk.

Furthermore, the OECD released its latest estimate of economic growth for 2021 on the 4th of December and, opposite to what the most bullish investors hoped, the international body did not upgrade its estimates for the major economies. The same happened with the 2021 outlook published by S&P Global.

Recent macroeconomic figures have not added hopes for a stronger recovery. The manufacturing and services PMI (purchasing managers’ index) for the eurozone showed deep contraction in services and a weakening trend in manufacturing with weak new orders and job losses even in November. The United States economy has published more robust figures, but the jobs slowdown is concerning. While manufacturing and services remain in expansion in November, the U.S. economy added less than a third of the jobs it increased in October, and the labor participation rate fell slightly to 61.5% with unemployment falling to 6.7%, driven mostly by concerns about new lockdowns and more taxes and rigidity in the jobs market if Joe Biden is confirmed as president.  Even the economies that were showing positive surprises in October are showing an important slowdown, as seen in the Daily Activity Index published by Bloomberg.

So why are markets so bullish? Central banks play a major role in this risk-taking frenzy. The balance sheet of the major central banks has soared to more than $20 trillion, the ECB balance sheet is now more than 61% of the GDP of the eurozone and the Federal Reserve exceeds 34%. Many market participants are using an often-repeated “Bad Is Good” strategy. A large number of investors ignore macro and debt data and increase bullish bets assuming that if figures remain weak, central banks will increase their stimulus plans.

Why is this dangerous? Central banks’ ignore the excessive market valuations and risk of asset bubbles created by their “expansionary” policies because they see these as small collateral damages of a wider and more important impact on the economy. As long as headline and core inflation in their economies remains weak or below target, they do not see any risk. But there are plenty.

  • The first risk is creating a debt and banking crisis. When rates remain artificially low for so long and solvency and liquidity ratios of borrowers deteriorate, the rise in non-performing loans and delinquencies is inevitable and bankruptcies pile despite massive liquidity injections. The accumulation of risk of the years of excess becomes the banking crisis of the “hangover” years.

  • The second risk is ignoring inflationary pressures on the goods and services citizens really use. A recent study from Bloomberg Economics showed that the inflation suffered by the middle-class and poor is up to three times higher than the official CPI (consumer price index). The Eurozone inflation shows this very clearly. While headline inflation has fallen to deflationary territory due to energy prices, fresh food has risen 4%, and consumers do not feel the headline 8% fall in “energy” because power, gasoline and diesel bills are not falling 8% at all including taxes. This difference between “low inflation” for central banks and rising cost of living for consumers is what created significant social conflicts throughout 2018 and 2019. In the United States, education, healthcare, insurance and fresh food are rising much faster than real wages.

  • The third risk is to create a perverse incentive in investors that fuels bubbles that create relevant ripple effects in the real economy when they burst. Central banks believe the risk of rising asset prices is contained but we know from the past that these “manageable” risks are rarely managed at all. Furthermore, when the biggest bubble in markets is sovereign debt, citizens suffer the risk in two ways, through higher taxes as deficits rise despite economic growth, and weaker purchasing power of savings and wages as central banks continue to use monetary policy to debase the value of their currencies.

Some investors may know that they are taking too much risk, but a large part also thinks that risk is gone because central banks will continue to implement stimuli, and this is really problematic. Too much debt and too much risk are not irrelevant factors, they mean lower growth, weaker productivity and higher probability of a crash in a few months. We have seen it in 2018, now in 2020.

Risk builds slowly and happens fast. Central banks cannot continue to ignore the insanity of sovereign bond valuations and the risk of concentration in markets. Low inflation is not an excuse to implement wrong policies even more aggressively. Governments cannot fall into the perverse incentive of recklessly adding debt because the cost is cheap. It is time to understand that the recovery will not come from larger deficit spending and monetary easing, but from prudent investment and saving. Demand-side policies have failed in this and the previous crisis. The solution to wrong policies is not to implement more of them. The world needs to stop this insane downward spiral of debt and constant bubble booms and busts.

The world needs more supply-side policies and less demand-side ones. This matters to everyone because the burst of the excessive optimism of these months of 2020 may end badly, not just for markets, but for an already crippled real economy.

Read More

Continue Reading

International

Analyst reviews Apple stock price target amid challenges

Here’s what could happen to Apple shares next.

Published

on

They said it was bound to happen.

It was Jan. 11, 2024 when software giant Microsoft  (MSFT)  briefly passed Apple  (AAPL)  as the most valuable company in the world.

Microsoft's stock closed 0.5% higher, giving it a market valuation of $2.859 trillion. 

It rose as much as 2% during the session and the company was briefly worth $2.903 trillion. Apple closed 0.3% lower, giving the company a market capitalization of $2.886 trillion. 

"It was inevitable that Microsoft would overtake Apple since Microsoft is growing faster and has more to benefit from the generative AI revolution," D.A. Davidson analyst Gil Luria said at the time, according to Reuters.

The two tech titans have jostled for top spot over the years and Microsoft was ahead at last check, with a market cap of $3.085 trillion, compared with Apple's value of $2.684 trillion.

Analysts noted that Apple had been dealing with weakening demand, including for the iPhone, the company’s main source of revenue. 

Demand in China, a major market, has slumped as the country's economy makes a slow recovery from the pandemic and competition from Huawei.

Sales in China of Apple's iPhone fell by 24% in the first six weeks of 2024 compared with a year earlier, according to research firm Counterpoint, as the company contended with stiff competition from a resurgent Huawei "while getting squeezed in the middle on aggressive pricing from the likes of OPPO, vivo and Xiaomi," said senior Analyst Mengmeng Zhang.

“Although the iPhone 15 is a great device, it has no significant upgrades from the previous version, so consumers feel fine holding on to the older-generation iPhones for now," he said.

A man scrolling through Netflix on an Apple iPad Pro. Photo by Phil Barker/Future Publishing via Getty Images.

Future Publishing/Getty Images

Big plans for China

Counterpoint said that the first six weeks of 2023 saw abnormally high numbers with significant unit sales being deferred from December 2022 due to production issues.

Apple is planning to open its eighth store in Shanghai – and its 47th across China – on March 21.

Related: Tech News Now: OpenAI says Musk contract 'never existed', Xiaomi's EV, and more

The company also plans to expand its research centre in Shanghai to support all of its product lines and open a new lab in southern tech hub Shenzhen later this year, according to the South China Morning Post.

Meanwhile, over in Europe, Apple announced changes to comply with the European Union's Digital Markets Act (DMA), which went into effect last week, Reuters reported on March 12.

Beginning this spring, software developers operating in Europe will be able to distribute apps to EU customers directly from their own websites instead of through the App Store.

"To reflect the DMA’s changes, users in the EU can install apps from alternative app marketplaces in iOS 17.4 and later," Apple said on its website, referring to the software platform that runs iPhones and iPads. 

"Users will be able to download an alternative marketplace app from the marketplace developer’s website," the company said.

Apple has also said it will appeal a $2 billion EU antitrust fine for thwarting competition from Spotify  (SPOT)  and other music streaming rivals via restrictions on the App Store.

The company's shares have suffered amid all this upheaval, but some analysts still see good things in Apple's future.

Bank of America Securities confirmed its positive stance on Apple, maintaining a buy rating with a steady price target of $225, according to Investing.com

The firm's analysis highlighted Apple's pricing strategy evolution since the introduction of the first iPhone in 2007, with initial prices set at $499 for the 4GB model and $599 for the 8GB model.

BofA said that Apple has consistently launched new iPhone models, including the Pro/Pro Max versions, to target the premium market. 

Analyst says Apple selloff 'overdone'

Concurrently, prices for previous models are typically reduced by about $100 with each new release. 

This strategy, coupled with installment plans from Apple and carriers, has contributed to the iPhone's installed base reaching a record 1.2 billion in 2023, the firm said.

More Tech Stocks:

Apple has effectively shifted its sales mix toward higher-value units despite experiencing slower unit sales, BofA said.

This trend is expected to persist and could help mitigate potential unit sales weaknesses, particularly in China. 

BofA also noted Apple's dominance in the high-end market, maintaining a market share of over 90% in the $1,000 and above price band for the past three years.

The firm also cited the anticipation of a multi-year iPhone cycle propelled by next-generation AI technology, robust services growth, and the potential for margin expansion.

On Monday, Evercore ISI analysts said they believed that the sell-off in the iPhone maker’s shares may be “overdone.”

The firm said that investors' growing preference for AI-focused stocks like Nvidia  (NVDA)  has led to a reallocation of funds away from Apple. 

In addition, Evercore said concerns over weakening demand in China, where Apple may be losing market share in the smartphone segment, have affected investor sentiment.

And then ongoing regulatory issues continue to have an impact on investor confidence in the world's second-biggest company.

“We think the sell-off is rather overdone, while we suspect there is strong valuation support at current levels to down 10%, there are three distinct drivers that could unlock upside on the stock from here – a) Cap allocation, b) AI inferencing, and c) Risk-off/defensive shift," the firm said in a research note.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

International

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high…

Published

on

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

Credit: IVI

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

 

The findings from this 4-year study, the Severe Typhoid in Africa (SETA) program, offers new typhoid fever burden estimates from six countries: Burkina Faso, Democratic Republic of the Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria, with four countries recording more than 100 cases for every 100,000 person-years of observation, which is considered a high burden. The highest incidence of typhoid was found in DRC with 315 cases per 100,000 people while children between 2-14 years of age were shown to be at highest risk across all 25 study sites.

 

There are an estimated 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths. However, with generic symptoms such as fever, fatigue, and abdominal pain, and the need for blood culture sampling to make a definitive diagnosis, it is difficult for governments to capture the true burden of typhoid in their countries.

 

“Our goal through SETA was to address these gaps in typhoid disease burden data,” said lead author Dr. Florian Marks, Deputy Director General of the International Vaccine Institute (IVI). “Our estimates indicate that introduction of TCV in endemic settings would go to lengths in protecting communities, especially school-aged children, against this potentially deadly—but preventable—disease.”

 

In addition to disease incidence, this study also showed that the emergence of antimicrobial resistance (AMR) in Salmonella Typhi, the bacteria that causes typhoid fever, has led to more reliance beyond the traditional first line of antibiotic treatment. If left untreated, severe cases of the disease can lead to intestinal perforation and even death. This suggests that prevention through vaccination may play a critical role in not only protecting against typhoid fever but reducing the spread of drug-resistant strains of the bacteria.

 

There are two TCVs prequalified by the World Health Organization (WHO) and available through Gavi, the Vaccine Alliance. In February 2024, IVI and SK bioscience announced that a third TCV, SKYTyphoid™, also achieved WHO PQ, paving the way for public procurement and increasing the global supply.

 

Alongside the SETA disease burden study, IVI has been working with colleagues in three African countries to show the real-world impact of TCV vaccination. These studies include a cluster-randomized trial in Agogo, Ghana and two effectiveness studies following mass vaccination in Kisantu, DRC and Imerintsiatosika, Madagascar.

 

Dr. Birkneh Tilahun Tadesse, Associate Director General at IVI and Head of the Real-World Evidence Department, explains, “Through these vaccine effectiveness studies, we aim to show the full public health value of TCV in settings that are directly impacted by a high burden of typhoid fever.” He adds, “Our final objective of course is to eliminate typhoid or to at least reduce the burden to low incidence levels, and that’s what we are attempting in Fiji with an island-wide vaccination campaign.”

 

As more countries in typhoid endemic countries, namely in sub-Saharan Africa and South Asia, consider TCV in national immunization programs, these data will help inform evidence-based policy decisions around typhoid prevention and control.

 

###

 

About the International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO) and developed a new-generation typhoid conjugate vaccine that is recently pre-qualified by WHO.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, a Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

CONTACT

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int


Read More

Continue Reading

International

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

Earlier today, CNBC’s…

Published

on

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever... And Debt Explodes

Earlier today, CNBC's Brian Sullivan took a horse dose of Red Pills when, about six months after our readers, he learned that the US is issuing $1 trillion in debt every 100 days, which prompted him to rage tweet, (or rageX, not sure what the proper term is here) the following:

We’ve added 60% to national debt since 2018. Germany - a country with major economic woes - added ‘just’ 32%.   

Maybe it will never matter.   Maybe MMT is real.   Maybe we just cancel or inflate it out. Maybe career real estate borrowers or career politicians aren’t the answer.

I have no idea.  Only time will tell.   But it’s going to be fascinating to watch it play out.

He is right: it will be fascinating, and the latest budget deficit data simply confirmed that the day of reckoning will come very soon, certainly sooner than the two years that One River's Eric Peters predicted this weekend for the coming "US debt sustainability crisis."

According to the US Treasury, in February, the US collected $271 billion in various tax receipts, and spent $567 billion, more than double what it collected.

The two charts below show the divergence in US tax receipts which have flatlined (on a trailing 6M basis) since the covid pandemic in 2020 (with occasional stimmy-driven surges)...

... and spending which is about 50% higher compared to where it was in 2020.

The end result is that in February, the budget deficit rose to $296.3 billion, up 12.9% from a year prior, and the second highest February deficit on record.

And the punchline: on a cumulative basis, the budget deficit in fiscal 2024 which began on October 1, 2023 is now $828 billion, the second largest cumulative deficit through February on record, surpassed only by the peak covid year of 2021.

But wait there's more: because in a world where the US is spending more than twice what it is collecting, the endgame is clear: debt collapse, and while it won't be tomorrow, or the week after, it is coming... and it's also why the US is now selling $1 trillion in debt every 100 days just to keep operating (and absorbing all those millions of illegal immigrants who will keep voting democrat to preserve the socialist system of the US, so beloved by the Soros clan).

And it gets even worse, because we are now in the ponzi finance stage of the Minsky cycle, with total interest on the debt annualizing well above $1 trillion, and rising every day

... having already surpassed total US defense spending and soon to surpass total health spending and, finally all social security spending, the largest spending category of all, which means that US debt will now rise exponentially higher until the inevitable moment when the US dollar loses its reserve status and it all comes crashing down.

We conclude with another observation by CNBC's Brian Sullivan, who quotes an email by a DC strategist...

.. which lays out the proposed Biden budget as follows:

The budget deficit will growth another $16 TRILLION over next 10 years. Thats *with* the proposed massive tax hikes.

Without them the deficit will grow $19 trillion.

That's why you will hear the "deficit is being reduced by $3 trillion" over the decade.

No family budget or business could exist with this kind of math.

Of course, in the long run, neither can the US... and since neither party will ever cut the spending which everyone by now is so addicted to, the best anyone can do is start planning for the endgame.

Tyler Durden Tue, 03/12/2024 - 18:40

Read More

Continue Reading

Trending